BPMC
$84.69
Revenue | $146.37Mn |
Net Profits | $-49.96Mn |
Net Profit Margins | -34.13% |
Blueprint Medicines Corp’s revenue jumped 103.41% since last year same period to $146.37Mn in the Q4 2024. On a quarterly growth basis, Blueprint Medicines Corp has generated 14.18% jump in its revenue since last 3-months.
Blueprint Medicines Corp’s net profit jumped 54.96% since last year same period to $-49.96Mn in the Q4 2024. On a quarterly growth basis, Blueprint Medicines Corp has generated 11.23% jump in its net profits since last 3-months.
Blueprint Medicines Corp’s net profit margin jumped 77.86% since last year same period to -34.13% in the Q4 2024. On a quarterly growth basis, Blueprint Medicines Corp has generated 22.26% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -1.66 |
EPS Estimate Current Year | -1.66 |
Blueprint Medicines Corp’s earning per share (EPS) estimates for the current quarter stand at -1.66 - a -132.46% fall from last quarter’s estimates.
Blueprint Medicines Corp’s earning per share (EPS) estimates for the current year stand at -1.66.
Earning Per Share (EPS) | -0.79 |
Blueprint Medicines Corp’s earning per share (EPS) jumped 56.59% since last year same period to -0.79 in the Q4 2024. This indicates that the Blueprint Medicines Corp has generated 56.59% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-10-30 | -0.97 | -0.89 | 8.25% |
2024-08-01 | -1.29 | -0.8 | 37.98% |
2024-05-02 | -1.66 | 1.4 | 184.34% |
2025-02-13 | -0.71 | -0.79 | -10.63% |